These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15583875)

  • 1. [Cardiovascular risk assessment for informed decision making. Validity of prediction tools].
    Lenz M; Mühlhauser I
    Med Klin (Munich); 2004 Nov; 99(11):651-61. PubMed ID: 15583875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of methods to identify individuals at increased risk of cardiovascular disease in Italian cohorts.
    Giavarina D; Barzon E; Cigolini M; Mezzena G; Soffiati G
    Nutr Metab Cardiovasc Dis; 2007 May; 17(4):311-8. PubMed ID: 17434054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.
    Riddell T; Wells S; Jackson R; Lee AW; Crengle S; Bramley D; Ameratunga S; Pylypchuk R; Broad J; Marshall R; Kerr A
    N Z Med J; 2010 Feb; 123(1309):50-61. PubMed ID: 20186242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCORE should be preferred to Framingham to predict cardiovascular death in French population.
    Marchant I; Boissel JP; Kassaï B; Bejan T; Massol J; Vidal C; Amsallem E; Naudin F; Galan P; Czernichow S; Nony P; Gueyffier F
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):609-15. PubMed ID: 20054289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Framingham Heart Study risk equation predicts first cardiovascular event rates in New Zealanders at the population level.
    Milne R; Gamble G; Whitlock G; Jackson R
    N Z Med J; 2003 Nov; 116(1185):U662. PubMed ID: 14615804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative ability of a risk-prediction tool derived from the Framingham Heart Study compared with single risk factors.
    Milne R; Gamble G; Whitlock G; Jackson R
    N Z Med J; 2003 Nov; 116(1185):U663. PubMed ID: 14615805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of cardiovascular risk scores in a liver transplant population.
    Guckelberger O; Mutzke F; Glanemann M; Neumann UP; Jonas S; Neuhaus R; Neuhaus P; Langrehr JM
    Liver Transpl; 2006 Mar; 12(3):394-401. PubMed ID: 16498651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of cardiovascular risk: a comparison between the Framingham and the SCORE model in people under 60 years of age.
    Scheltens T; Verschuren WM; Boshuizen HC; Hoes AW; Zuithoff NP; Bots ML; Grobbee DE
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):562-6. PubMed ID: 18756178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of total cardiovascular risk assessment in clinical practice.
    Graham IM
    Eur J Gen Pract; 2006; 12(4):148-55. PubMed ID: 17127600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiovascular risk assessment by primary-care physicians in Germany and its lack of agreement with the Established Risk Scores (DETECT)].
    Silber S; Jarre F; Pittrow D; Klotsche J; Pieper L; Zeiher AM; Wittchen HU;
    Med Klin (Munich); 2008 Sep; 103(9):638-45. PubMed ID: 18813887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fewer deaths from cardiovascular disease than expected from the Systematic Coronary Risk Evaluation chart in a Swedish population.
    Stenlund H; Lönnberg G; Jenkins P; Norberg M; Persson M; Messner T; Boman K; Pearson T; Wall S; Nyström L; Weinehall L
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):321-4. PubMed ID: 19357519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of using different methods to assess cardiovascular risk in primary care.
    Fornasini M; Brotons C; Sellarès J; Martinez M; Galán ML; Sáenz I; da Pena JM
    Fam Pract; 2006 Feb; 23(1):28-33. PubMed ID: 16243952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
    Hamer M; Chida Y; Stamatakis E
    Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of the absolute global cardiovascular risk: comparison between the risk chart and the individual score of the CUORE Project].
    Giampaoli S; Palmieri L; Donfrancesco C; Panico S; Pilotto L; Addis A; Boccanelli A; Di Pasquale G; Brignoli O; Filippi A; Vanuzzo D;
    G Ital Cardiol (Rome); 2006 May; 7(5):359-64. PubMed ID: 16752519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The estimate of cardiovascular risk. Theory, tools and problems.
    Menotti A; Puddu PE; Lanti M
    Ann Ital Med Int; 2002; 17(2):81-94. PubMed ID: 12150050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
    Shah DS; Polkinghorne KR; Pellicano R; Kerr PG
    Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the obesity surgery mortality risk score in a multicenter study proves it stratifies mortality risk in patients undergoing gastric bypass for morbid obesity.
    DeMaria EJ; Murr M; Byrne TK; Blackstone R; Grant JP; Budak A; Wolfe L
    Ann Surg; 2007 Oct; 246(4):578-82; discussion 583-4. PubMed ID: 17893494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.